From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Pediatrics and Adolescent Medicine>
  4. Summary and Comment

The Impact of Varicella Vaccine

Ten years after the introduction of universal vaccination, researchers see signs of worth.

The introduction of the universal childhood varicella vaccination program in 1995 was controversial because many clinicians and parents did not believe in the need to immunize for a "benign" disease. CDC investigators have tallied the annual deaths, from 1990 through 2001, in which varicella was the underlying or contributing cause.

Deaths attributable to varicella declined significantly after introduction of the vaccine: from 105 deaths per year in the period 1990-1994 to 48 in 1999, 40 in 2000, and 26 in 2001. Deaths in which varicella was a contributing cause also declined, from 39.6 per year in the period 1990-1994 to 26.7 per year in the period 1999-2001. The average age-adjusted mortality rate for varicella as an underlying or contributing cause declined by 59%, from 0.56/1,000,000 in 1990-1994 to 0.23/1,000,000 in 1999-2001. Although death rates declined in all age groups below 50 years, the greatest decline (92%) was among children aged 1 to 4 years. Mortality rates were similar in all racial and ethnic groups and regardless of birthplace.

Comment: The addition of varicella vaccine to the routine immunization schedule has been worthwhile. Aside from reduced mortality rates, the rates of other adverse effects related to varicella infection have also declined (e.g., missed school or work, hospitalization for complications). Whether waning immunity will necessitate repeat vaccination remains an important question.

— Howard Bauchner, MD

Published in Journal Watch Pediatrics and Adolescent Medicine February 28, 2005

Citation(s):

Nguyen HQ et al. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 2005 Feb 3; 352:450-8.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2005. Massachusetts Medical Society. All rights reserved.